You’re Invited – The Economic Impact of the Opioid Epidemic: Labor Supply and the Workplace
The economic impact of the opioid epidemic: Labor supply and the workplace
|
The opioid epidemic has had far-reaching consequences, including on the workforce. Opioid addiction affects the labor supply through decreased labor force participation and reduced hours of work for employees. At the same time, employers are seeking to foster supportive work environments for employees in recovery from substance use disorder (SUD), which can require altering business processes.
On April 18, the USC-Brookings Schaeffer Initiative for Health Policy will welcome Dr. Rahul Gupta, director of the White House Office of National Drug Control Policy, and Julie Wernau of the Wall Street Journal for a fireside chat on the opioid epidemic’s impact on the labor force and how workplaces can become recovery-friendly.
The fireside chat will be followed by an expert panel discussion on policies, programs, and strategies that can support SUD recovery and foster continued participation in the labor force for individuals in recovery. The panel will include Dr. Tisamarie Sherry (U.S. Department of Health and Human Services), Kyle Zimmer (International Union of Operating Engineers), Dana Lariviere (Chameleon Group), and will be moderated by Richard Frank (Brookings.)
This event will be open for in-person attendance or to watch online. Online viewers can submit questions by emailing [email protected] or tweeting @BrookingsEcon using #RecoveryFriendly.
Registration is required to attend an event in person and guests at Brookings are required to attest to their state of health before attending. Visitors may not enter the building if they are feeling ill for any reason, have any symptoms commonly associated with COVID-19, or have tested positive for COVID-19 at any time in the preceding 14 days.
Welcome Richard G. Frank, Senior Fellow and Director, USC-Brookings Schaeffer Initiative for Health Policy, Brookings
Fireside chat Moderator: Julie Wernau, Reporter, Wall Street Journal Rahul Gupta, Director, White House Office of National Drug Control Policy
Panel discussion Moderator: Richard G. Frank, Senior Fellow and Director, USC-Brookings Schaeffer Initiative for Health Policy, Brookings Dana Lariviere, President and CEO, Chameleon Group Tisamarie Sherry, Deputy Assistant Secretary for Behavioral Health, Disability and Aging Policy, Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services Kyle Zimmer, Health and Safety Director and Members Assistance Program Director, IUOE Local 478, International Union of Operating Engineers | |
